Dominik Lutter

Dr. Dominik Lutter

Computational Discovery ResearchInstitute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Cell
Verified
Journal Article
Closed access
KDKenneth A. Dyar
Kenneth A. Dyar
Dominik LutterDominik Lutter
Dominik Lutter
AAAnna Artati
Anna Artati
NCNicholas J. Ceglia
Nicholas J. Ceglia
YLYu Liu
Yu Liu
PSPaolo Sassone-Corsi
Paolo Sassone-Corsi

13 January 2022 in Cell Metabolism
Verified
Journal Article
Open access
SSShogo Sato
Shogo Sato
KDKenneth A. Dyar
Kenneth A. Dyar
JTJonas Thue Treebak
Jonas Thue Treebak
SJSara L. Jepsen
Sara L. Jepsen
AEAmy M. Ehrlich
Amy M. Ehrlich
PSPaolo Sassone-Corsi
Paolo Sassone-Corsi
Tissue sensitivity and response to exercise vary according to the time of day and alignment of circadian clocks, but the optimal exercise time to elicit a desired metabolic outcome is not fully defined. To understand how tissues independently and collectively respond to timed exercise, we applied a systems biology approach. We mapped and compared global metabolite responses of seven different mouse tissues and serum after an acute exercise bout performed at different times of the day. Comparative analyses of intra- and inter-tissue metabolite dynamics, including temporal profiling and blood sampling across liver and hindlimb muscles, uncovered an unbiased view of local and systemic metabolic responses to exercise unique to time of day. This comprehensive atlas of exercise metabolism provides clarity and physiological context regarding the production and distribution of canonical and novel time-dependent exerkine metabolites, such as 2-hydroxybutyrate (2-HB), and reveals insight into the health-promoting benefits of exercise on metabolism.

1 May 2019 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
SSStephan Sachs
Stephan Sachs
SZSimona Zarini
Simona Zarini
DKDarcy E. Kahn
Darcy E. Kahn
KHKathleen A. Harrison
Kathleen A. Harrison
LPLeigh Perreault
Leigh Perreault
BBBryan C. Bergman
Bryan C. Bergman
Intermuscular adipose tissue (IMAT) is negatively related to insulin sensitivity, but a causal role of IMAT in the development of insulin resistance is unknown. IMAT was sampled in humans to test for the ability to induce insulin resistance in vitro and characterize gene expression to uncover how IMAT may promote skeletal muscle insulin resistance. Human primary muscle cells were incubated with conditioned media from IMAT, visceral (VAT), or subcutaneous adipose tissue (SAT) to evaluate changes in insulin sensitivity. RNAseq analysis was performed on IMAT with gene expression compared with skeletal muscle and SAT, and relationships to insulin sensitivity were determined in men and women spanning a wide range of insulin sensitivity measured by hyperinsulinemic-euglycemic clamp. Conditioned media from IMAT and VAT decreased insulin sensitivity similarly compared with SAT. Multidimensional scaling analysis revealed distinct gene expression patterns in IMAT compared with SAT and muscle. Pathway analysis revealed that IMAT expression of genes in insulin signaling, oxidative phosphorylation, and peroxisomal metabolism related positively to donor insulin sensitivity, whereas expression of macrophage markers, inflammatory cytokines, and secreted extracellular matrix proteins were negatively related to insulin sensitivity. Perilipin 5 gene expression suggested greater IMAT lipolysis in insulin-resistant individuals. Combined, these data show that factors secreted from IMAT modulate muscle insulin sensitivity, possibly via secretion of inflammatory cytokines and extracellular matrix proteins, and by increasing local FFA concentration in humans. These data suggest IMAT may be an important regulator of skeletal muscle insulin sensitivity and could be a novel therapeutic target for skeletal muscle insulin resistance.

1 October 2016 in Cell
Verified
Journal Article
Closed access
BFBrian Finan
Brian Finan
CCChristoffer Clemmensen
Christoffer Clemmensen
ZZZhimeng Zhu
Zhimeng Zhu
KSKerstin Stemmer
Kerstin Stemmer
KGKarine Gauthier
Karine Gauthier
TMTimo D. Müller
Timo D. Müller

3 October 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MAManuel Albanese
Manuel Albanese
TTTakanobu Tagawa
Takanobu Tagawa
MBMickaël Bouvet
Mickaël Bouvet
LMLiridona Maliqi
Liridona Maliqi
Dominik LutterDominik Lutter
Dominik Lutter
WHWolfgang Hammerschmidt
Wolfgang Hammerschmidt
Significance: Most humans are infected for their lifetime with Epstein–Barr virus (EBV), which can cause cancer and other EBV-associated diseases. Infected individuals develop strong immune responses to this virus, in particular cytotoxic CD8 + T cells, but viral infection is never cleared nor is EBV eliminated from the body. This suggests that certain viral molecules might prevent effective elimination of EBV-infected cells by CD8 + T cells. EBV is rich in genes coding for microRNAs, many with unknown function. We show that viral microRNAs interfere with recognition and killing of EBV-infected cells by CD8 + T cells. Multiple mechanisms and molecules are targeted by microRNAs to achieve this immune evasion. Therefore, targeting of viral microRNAs may improve antiviral immunity and therapy.

10 August 2018 in PLOS Biology
Verified
Journal Article
Open access
PDF file
KDKenneth A. Dyar
Kenneth A. Dyar
MHMichaël Jean Hubert
Michaël Jean Hubert
AMAshfaq Ali Mir
Ashfaq Ali Mir
Stefano CiciliotStefano Ciciliot
Stefano Ciciliot
Dominik LutterDominik Lutter
Dominik Lutter
NUN. Henriette Uhlenhaut
N. Henriette Uhlenhaut
Circadian clocks are fundamental physiological regulators of energy homeostasis, but direct transcriptional targets of the muscle clock machinery are unknown. To understand how the muscle clock directs rhythmic metabolism, we determined genome-wide binding of the master clock regulators brain and muscle ARNT-like protein 1 (BMAL1) and REV-ERBα in murine muscles. Integrating occupancy with 24-hr gene expression and metabolomics after muscle-specific loss of BMAL1 and REV-ERBα, here we unravel novel molecular mechanisms connecting muscle clock function to daily cycles of lipid and protein metabolism. Validating BMAL1 and REV-ERBα targets using luciferase assays and in vivo rescue, we demonstrate how a major role of the muscle clock is to promote diurnal cycles of neutral lipid storage while coordinately inhibiting lipid and protein catabolism prior to awakening. This occurs by BMAL1-dependent activation of Dgat2 and REV-ERBα-dependent repression of major targets involved in lipid metabolism and protein turnover (MuRF-1, Atrogin-1). Accordingly, muscle-specific loss of BMAL1 is associated with metabolic inefficiency, impaired muscle triglyceride biosynthesis, and accumulation of bioactive lipids and amino acids. Taken together, our data provide a comprehensive overview of how genomic binding of BMAL1 and REV-ERBα is related to temporal changes in gene expression and metabolite fluctuations. Circadian clocks are known to regulate local and systemic homeostasis by anticipating rhythmic changes in behavior and nutritional state and by compartmentalizing incompatible metabolic pathways within precise temporal and spatial windows. Yet a precise mechanistic understanding of how the circadian clock in skeletal muscle controls homeostasis is just beginning to come to light. Here, we investigated how the muscle clock directs 24-hr metabolic rhythms. We compared genome-wide binding of clock transcription factors brain and muscle ARNT-like protein 1 (BMAL1) and REV-ERBα with 24-hr transcriptional and metabolic effects after their loss of function specifically in muscles. We found that the muscle clock plays a major role anticipating the transition from fasting to feeding. This occurs by direct activation of transcriptional programs promoting lipid storage, insulin sensitivity, and glucose metabolism, with coordinated repression of programs controlling lipid oxidation and protein catabolism. Importantly, these gene expression changes occur in the hours prior to systemic metabolic and hormonal cues that arise upon awakening. As such, we find that the muscle clock tips the scales in favor of glucose metabolism, whereas loss of function of the clock transcription factor BMAL1 is associated with persistent lipid metabolism, protein catabolism, and metabolic inefficiency.